Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilan Athauda

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Aging Clinical and Experimental Research|November 5, 2014
Clinically silent idiopathic Parkinson's disease unmasked by valproate use: a brief reportDilan Athauda, Robert Batley, Catherine Ellis
Journal of Parkinson'S Disease|August 5, 2017
Is Exenatide a Treatment for Parkinson's Disease?Dilan Athauda, Richard Wyse, Patrik Brundin, et al.
Case Reports in Neurological Medicine|April 10, 2014
High grade glioma mimicking voltage gated potassium channel complex associated antibody limbic encephalitisDilan Athauda, R S Delamont, E De Pablo-Fernandez
Endoscopy|April 24, 2014
Cerebral air embolism during endoscopic retrograde cholangiopancreatography: treatment with therapeutic hypothermiaDilan Athauda, Garryck S Tan, Eduardo De Pablo-Fernandez
Journal of Neurology|October 15, 2011
Multiphasic acute disseminated encephalomyelitis (ADEM) following influenza type A (swine specific H1N1)Dilan Athauda, Thomasin C Andrews, Paul A Holmes, et al.
Drugs & Aging|March 19, 2021
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and SuitabilityChristine Girges, Nirosen Vijiaratnam, Dilan Athauda, et al.
Frontiers in Aging Neuroscience|July 3, 2023
Commentary: "Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis"Michael Lawton, Yoav Ben-Shlomo, Dilan Athauda, et al.
Practical Neurology|February 15, 2018
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitisAngeliki Zarkali, Oliver Cousins, Dilan Athauda, et al.
The Journal of Clinical Investigation|February 16, 2026
The promise of GLP-1 receptor agonists for neurodegenerative diseasesDilan Athauda, Nigel H Greig, Wassilios G Meissner, et al.
Brain : a Journal of Neurology|May 23, 2026
Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trialRowan Gurney, Christine Girges, Nirosen Vijiaratnam, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Aging Clinical and Experimental Research|November 5, 2014
Clinically silent idiopathic Parkinson's disease unmasked by valproate use: a brief reportDilan Athauda, Robert Batley, Catherine Ellis
Journal of Parkinson'S Disease|August 5, 2017
Is Exenatide a Treatment for Parkinson's Disease?Dilan Athauda, Richard Wyse, Patrik Brundin, et al.
Case Reports in Neurological Medicine|April 10, 2014
High grade glioma mimicking voltage gated potassium channel complex associated antibody limbic encephalitisDilan Athauda, R S Delamont, E De Pablo-Fernandez
Endoscopy|April 24, 2014
Cerebral air embolism during endoscopic retrograde cholangiopancreatography: treatment with therapeutic hypothermiaDilan Athauda, Garryck S Tan, Eduardo De Pablo-Fernandez
Journal of Neurology|October 15, 2011
Multiphasic acute disseminated encephalomyelitis (ADEM) following influenza type A (swine specific H1N1)Dilan Athauda, Thomasin C Andrews, Paul A Holmes, et al.
Drugs & Aging|March 19, 2021
The Future of Incretin-Based Approaches for Neurodegenerative Diseases in Older Adults: Which to Choose? A Review of their Potential Efficacy and SuitabilityChristine Girges, Nirosen Vijiaratnam, Dilan Athauda, et al.
Frontiers in Aging Neuroscience|July 3, 2023
Commentary: "Association between diabetes mellitus, prediabetes and risk, disease progression of Parkinson's disease: a systematic review and meta-analysis"Michael Lawton, Yoav Ben-Shlomo, Dilan Athauda, et al.
Practical Neurology|February 15, 2018
Glial fibrillary acidic protein antibody-positive meningoencephalomyelitisAngeliki Zarkali, Oliver Cousins, Dilan Athauda, et al.
The Journal of Clinical Investigation|February 16, 2026
The promise of GLP-1 receptor agonists for neurodegenerative diseasesDilan Athauda, Nigel H Greig, Wassilios G Meissner, et al.
Brain : a Journal of Neurology|May 23, 2026
Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trialRowan Gurney, Christine Girges, Nirosen Vijiaratnam, et al.
Pageof 6